Integrative clustering analysis to discover novel IPF disease subtypes in the IPF-PRO Registry

Y. Liu (Ridgefield, Connecticut, United States of America), H. Lin (Pittsburgh, Pennsylvania, United States of America), J. Soellner (Biberach, Germany), J. Roy (Munich, Germany), R. Vinisko (Ridgefield, Connecticut, United States of America), R. Schmid (Biberach, Germany), B. Strobel (Biberach, Germany), J. Belperio (Los Angeles, California, United States of America), J. De Andrade (Nashville, Tennessee, United States of America), K. Flaherty (Ann Arbor, Michigan, United States of America), J. Lasky (New Orleans, Louisiana, United States of America), T. Luckhardt (Birmingham, Alabama, United States of America), M. Neely (Durham, North Carolina, United States of America), C. Hesslinger (Biberach, Germany), S. Palmer (Durham, North Carolina, United States of America), T. Leonard (Ridgefield, Connecticut, United States of America), J. Todd (Durham, North Carolina, United States of America), M. Salisbury (Nashville, Tennessee, United States of America)

Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Session: Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 733
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Liu (Ridgefield, Connecticut, United States of America), H. Lin (Pittsburgh, Pennsylvania, United States of America), J. Soellner (Biberach, Germany), J. Roy (Munich, Germany), R. Vinisko (Ridgefield, Connecticut, United States of America), R. Schmid (Biberach, Germany), B. Strobel (Biberach, Germany), J. Belperio (Los Angeles, California, United States of America), J. De Andrade (Nashville, Tennessee, United States of America), K. Flaherty (Ann Arbor, Michigan, United States of America), J. Lasky (New Orleans, Louisiana, United States of America), T. Luckhardt (Birmingham, Alabama, United States of America), M. Neely (Durham, North Carolina, United States of America), C. Hesslinger (Biberach, Germany), S. Palmer (Durham, North Carolina, United States of America), T. Leonard (Ridgefield, Connecticut, United States of America), J. Todd (Durham, North Carolina, United States of America), M. Salisbury (Nashville, Tennessee, United States of America). Integrative clustering analysis to discover novel IPF disease subtypes in the IPF-PRO Registry. 733

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Microarray cluster analysis reveals individual genes and biological processes associated with COPD
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014


Combined analysis of gene expression and clinical data in the severe asthma U-BIOPRED cohorts
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014



Proteome fingerprints define groups with distinct clinico-pathological phenotypes in the U-BIOPRED asthma study
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Association between candidate gene polymorphisms and asthma severity in adults. A Bayesian analysis
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016

High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013



Genome-wide association study identifies new COPD risk locus, PDE4D, in Korean population
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013


A multi-omics data integration approach to identify a predictive molecular signature of CLAD
Source: International Congress 2015 – Predictors of lung transplant complications
Year: 2015



Re-sequencing of PLAUR in severe asthma patients identifies novel variation
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014

Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015


Clinical COPD phenotypes: a novel approach using principal component and cluster analyses
Source: Eur Respir J 2010; 36: 531-539
Year: 2010



Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis
Source: Eur Respir J 2014; 44: 860-872
Year: 2014



Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

Cluster analysis to identify phenotypes in COPD
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009

Integrated analysis of COPD gene expression data reveals specific pathway signatures
Source: Annual Congress 2010 - Genetics of obstruction
Year: 2010


LSC Abstract – Unsupervised gene co-expression analysis identifies a novel endotype in severe asthma
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016

LSC Abstract – Identification of distinct biological phenotypes of ARDS by cluster analysis and association with mortality
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016


Gene signatures from U-BIOPRED transcriptomic-associated clusters exist in COPD
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017



Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes
Source: Eur Respir J 2014; 44: 985-993
Year: 2014



Longitudinal validation of clinical COPD phenotypes identified by cluster analysis
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011

Genetic heterogeneity of asthma phenotypes identified by a clustering approach
Source: Eur Respir J 2014; 43: 439-452
Year: 2013